Matches in SemOpenAlex for { <https://semopenalex.org/work/W3109089875> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- W3109089875 endingPage "119258" @default.
- W3109089875 startingPage "119258" @default.
- W3109089875 abstract "Empagliflozin and linagliptin are newly approved FDA combination that used for the treatment of type 2 diabetes mellitus (T2DM) under trade name Glxambi. Two spectroflourimetric methods were developed for simple quantitative determination of empagliflozin and linagliptin in their pharmaceutical formulation and human plasma without need any tedious processing operations. Empagliflozin has a native fluorescence nature, therefore can be directly determined by measuring emission peak at 305 nm after excitation at 234 nm. There is no any interference from linagliptin at this emission wavelength. On the other hand, linagliptin is a very weak florescent compound that needs to react with fluorogenic reagent to be quantitatively determined without any reaction of empagliflozin. So, quantitative analysis of linagliptin was achieved by coupling with NBD-Cl which is an electro active halide reagent (targeting only Linagliptin with no effect on empagliflozin). Dark yellow fluorophore with high fluorescence is a result of this reaction and can be measured at emission wavelength 538 nm after excition at wavelength 469 nm. Experimental conditions of the suggested methods were well checked and optimized. The regression plots were found to be linear over the range of 40–1200 ng/mL and 3–700 ng/mL for empagliflozin and linagliptin, respectively. The obtained results by the suggested methods were statistically compared with those obtained by the reported methods, showing no significant difference with respect to accuracy and precision at p = 0.05." @default.
- W3109089875 created "2020-12-07" @default.
- W3109089875 creator A5046487364 @default.
- W3109089875 creator A5050988821 @default.
- W3109089875 creator A5052125752 @default.
- W3109089875 creator A5055661749 @default.
- W3109089875 creator A5088032232 @default.
- W3109089875 date "2021-03-01" @default.
- W3109089875 modified "2023-10-16" @default.
- W3109089875 title "Flourimetric study on antidiabetic combined drugs; empagliflozin and linagliptin in their pharmaceutical formulation and human plasma" @default.
- W3109089875 cites W1980847189 @default.
- W3109089875 cites W1983834897 @default.
- W3109089875 cites W2000663519 @default.
- W3109089875 cites W2004666747 @default.
- W3109089875 cites W2021398818 @default.
- W3109089875 cites W2038708044 @default.
- W3109089875 cites W2049287701 @default.
- W3109089875 cites W2082490856 @default.
- W3109089875 cites W2110283887 @default.
- W3109089875 cites W2110972117 @default.
- W3109089875 cites W2128219379 @default.
- W3109089875 cites W2155873662 @default.
- W3109089875 cites W2314880155 @default.
- W3109089875 cites W2604742694 @default.
- W3109089875 cites W2607258518 @default.
- W3109089875 cites W2785429876 @default.
- W3109089875 cites W2795273140 @default.
- W3109089875 cites W3015458242 @default.
- W3109089875 doi "https://doi.org/10.1016/j.saa.2020.119258" @default.
- W3109089875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33310272" @default.
- W3109089875 hasPublicationYear "2021" @default.
- W3109089875 type Work @default.
- W3109089875 sameAs 3109089875 @default.
- W3109089875 citedByCount "8" @default.
- W3109089875 countsByYear W31090898752021 @default.
- W3109089875 countsByYear W31090898752022 @default.
- W3109089875 countsByYear W31090898752023 @default.
- W3109089875 crossrefType "journal-article" @default.
- W3109089875 hasAuthorship W3109089875A5046487364 @default.
- W3109089875 hasAuthorship W3109089875A5050988821 @default.
- W3109089875 hasAuthorship W3109089875A5052125752 @default.
- W3109089875 hasAuthorship W3109089875A5055661749 @default.
- W3109089875 hasAuthorship W3109089875A5088032232 @default.
- W3109089875 hasConcept C120665830 @default.
- W3109089875 hasConcept C121332964 @default.
- W3109089875 hasConcept C134018914 @default.
- W3109089875 hasConcept C147789679 @default.
- W3109089875 hasConcept C185592680 @default.
- W3109089875 hasConcept C192562407 @default.
- W3109089875 hasConcept C2775887513 @default.
- W3109089875 hasConcept C2777180221 @default.
- W3109089875 hasConcept C2778617687 @default.
- W3109089875 hasConcept C2780031085 @default.
- W3109089875 hasConcept C2993001476 @default.
- W3109089875 hasConcept C40875361 @default.
- W3109089875 hasConcept C43617362 @default.
- W3109089875 hasConcept C49040817 @default.
- W3109089875 hasConcept C555293320 @default.
- W3109089875 hasConcept C6260449 @default.
- W3109089875 hasConcept C71924100 @default.
- W3109089875 hasConcept C91881484 @default.
- W3109089875 hasConceptScore W3109089875C120665830 @default.
- W3109089875 hasConceptScore W3109089875C121332964 @default.
- W3109089875 hasConceptScore W3109089875C134018914 @default.
- W3109089875 hasConceptScore W3109089875C147789679 @default.
- W3109089875 hasConceptScore W3109089875C185592680 @default.
- W3109089875 hasConceptScore W3109089875C192562407 @default.
- W3109089875 hasConceptScore W3109089875C2775887513 @default.
- W3109089875 hasConceptScore W3109089875C2777180221 @default.
- W3109089875 hasConceptScore W3109089875C2778617687 @default.
- W3109089875 hasConceptScore W3109089875C2780031085 @default.
- W3109089875 hasConceptScore W3109089875C2993001476 @default.
- W3109089875 hasConceptScore W3109089875C40875361 @default.
- W3109089875 hasConceptScore W3109089875C43617362 @default.
- W3109089875 hasConceptScore W3109089875C49040817 @default.
- W3109089875 hasConceptScore W3109089875C555293320 @default.
- W3109089875 hasConceptScore W3109089875C6260449 @default.
- W3109089875 hasConceptScore W3109089875C71924100 @default.
- W3109089875 hasConceptScore W3109089875C91881484 @default.
- W3109089875 hasLocation W31090898751 @default.
- W3109089875 hasOpenAccess W3109089875 @default.
- W3109089875 hasPrimaryLocation W31090898751 @default.
- W3109089875 hasRelatedWork W1832316380 @default.
- W3109089875 hasRelatedWork W2059079195 @default.
- W3109089875 hasRelatedWork W2134652590 @default.
- W3109089875 hasRelatedWork W2148119499 @default.
- W3109089875 hasRelatedWork W2155873662 @default.
- W3109089875 hasRelatedWork W3077048812 @default.
- W3109089875 hasRelatedWork W3112570488 @default.
- W3109089875 hasRelatedWork W3124538466 @default.
- W3109089875 hasRelatedWork W3158760537 @default.
- W3109089875 hasRelatedWork W4282913394 @default.
- W3109089875 hasVolume "248" @default.
- W3109089875 isParatext "false" @default.
- W3109089875 isRetracted "false" @default.
- W3109089875 magId "3109089875" @default.
- W3109089875 workType "article" @default.